TARO-DOCETAXEL DIN 02465647
Health Canada record
| Active ingredient(s) | DOCETAXEL 80 MG |
|---|---|
| Dosage form | Solution |
| Route | Intravenous |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | L01CD02 DOCETAXEL |
| Original market date | |
| Current status date | 11-Jul-2022 |
| Source | Health Canada DPD |
Establishment licence of the holder
Taro Pharmaceuticals Inc — licence 100232, not currently licensed, last inspection rating C (2025-03-24).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing DOCETAXEL
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02439336 | DOCETAXEL INJECTION | SANDOZ CANADA INCORPORATED | Solution | DOCETAXEL 10 MG | Marketed |
| 02458020 | DOCETAXEL INJECTION | BIOLYSE PHARMA CORPORATION | Solution | DOCETAXEL 20 MG | Marketed |
| 02361957 | DOCETAXEL INJECTION USP | PFIZER CANADA ULC | Solution | DOCETAXEL 10 MG | Marketed |
| 02444410 | ACT DOCETAXEL 40 MG/ML | ACTAVIS PHARMA COMPANY | Solution | DOCETAXEL 20 MG | Cancelled Pre Market |
| 02441845 | ACT DOCETAXEL 40 MG/ML | ACTAVIS PHARMA COMPANY | Solution | DOCETAXEL 80 MG | Cancelled Pre Market |
| 02437031 | DOCETAXEL INJECTION | ACCORD HEALTHCARE INC | Solution | DOCETAXEL 20 MG | Dormant |
| 02412225 | DOCETAXEL INJECTION | TEVA CANADA LIMITED | Solution | DOCETAXEL 20 MG | Cancelled Post Market |
| 02412233 | DOCETAXEL INJECTION | TEVA CANADA LIMITED | Solution | DOCETAXEL 80 MG | Cancelled Post Market |
| 02436361 | PMS-DOCETAXEL | PHARMASCIENCE INC | Kit; Solution | DOCETAXEL 20 MG | Cancelled Pre Market |
| 02436388 | PMS-DOCETAXEL | PHARMASCIENCE INC | Kit; Solution | DOCETAXEL 80 MG | Cancelled Pre Market |
| 02465655 | TARO-DOCETAXEL | TARO PHARMACEUTICALS INC | Solution | DOCETAXEL 160 MG | Cancelled Pre Market |
| 02465531 | TARO-DOCETAXEL | TARO PHARMACEUTICALS INC | Solution | DOCETAXEL 20 MG | Cancelled Pre Market |
| 02177080 | TAXOTERE | SANOFI-AVENTIS CANADA INC | Solution | DOCETAXEL 80 MG | Cancelled Post Market |
| 02177099 | TAXOTERE | SANOFI-AVENTIS CANADA INC | Solution | DOCETAXEL 20 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 19473 | 2017-06-30 | Abbreviated New Drug Submission (ANDS) |
International API supply for DOCETAXEL
13 valid EDQM Certificates of Suitability from 13 holders. 24 active FDA Drug Master Files.
Request a quote for TARO-DOCETAXEL